Publication: Predictors of mortality after MitraClip therapy
Loading...
Program
KU-Authors
Organization Authors
Co-Authors
Marmagkiolis, Konstantinos
Date
Language
Type
Embargo Status
N/A
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
Percutaneous mitral valve repair with Mitraclip remains to be the preferred therapy for those patients with congestive heart failure with severe mitral regurgitation who are deemed high-surgical risk. Failure of successful MR reduction, preprocedural NYHA functional class III-IV, elevated ProBNP levels, presence of severe tricuspid regurgitation, pulmonary hypertension, right ventricular dysfunction and advanced age seems to be predictors of long term mortality. Preprocedural patient characteristics needs to be carefully evaluated for optimal patient selection for Mitraclip therapy.
Source
Publisher
Wiley
Citation
item.page.haspartof
Source
Catheterization and Cardiovascular Interventions
item.page.ispartofseries
item.page.edition
DOI
10.1002/ccd.26431
item.page.datauri
item.page.link
Rights
N/A
Copyrights Note
Rights and licensing
N/A
